Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2000
12/21/2000WO2000077206A2 The myostatin gene promoter and inhibition of activation thereof
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077191A1 Tumor necrosis factor related receptor, tr6
12/21/2000WO2000077186A2 Bacterial protection against stress
12/21/2000WO2000077184A1 Caspase-8 crystals, models and methods
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
12/21/2000WO2000077040A2 Human intracellular signaling molecules
12/21/2000WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/21/2000WO2000077030A1 Statine-derived tetrapeptide inhibitors of beta-secretase
12/21/2000WO2000077018A2 Purine derivatives
12/21/2000WO2000077010A2 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077004A1 1-azatricyclic-4-benzylpiperazines
12/21/2000WO2000077002A1 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077001A1 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000076993A1 Benzazepine derivatives, process for the preparation of the same and uses thereof
12/21/2000WO2000076988A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/21/2000WO2000076984A2 Novel compounds, their use and preparation
12/21/2000WO2000076980A1 Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
12/21/2000WO2000076974A2 Oligomers and polymers of cyclic imino carboxylic acids
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076969A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000WO2000076962A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/21/2000WO2000076961A1 Inhibitors of aspartyl protease
12/21/2000WO2000076958A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/21/2000WO2000076957A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
12/21/2000WO2000076953A1 Benzene derivatives, preparation method and pharmaceutical compositions containing same
12/21/2000WO2000076556A2 High dose radionuclide complexes for bone marrow suppression
12/21/2000WO2000076552A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000WO2000076551A2 Method for producing an injectable medicament preparation
12/21/2000WO2000076545A1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
12/21/2000WO2000076542A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076527A2 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
12/21/2000WO2000076523A1 Methods for modulating fxr receptor activity
12/21/2000WO2000076518A1 Urea substituted imidazoquinolines
12/21/2000WO2000076516A1 Il-8 receptor antagonists
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076497A1 Cancer therapy
12/21/2000WO2000076495A1 Il-8 receptor antagonists
12/21/2000WO2000076478A1 Controlled release and taste masking oral pharmaceutical compositions
12/21/2000WO2000076457A2 Il-8 receptor antagonists
12/21/2000WO2000076452A2 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000050062A3 Methods and compositions for altering mucus secretion
12/21/2000WO2000047762A3 Enriched central nervous system cell populations
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000WO2000044361A3 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
12/21/2000WO2000031094A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
12/21/2000WO2000020041A8 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
12/21/2000WO2000007577A8 Phosphatidylcholine as a medicament for the protection of mucosa
12/21/2000EP1144671A3 Enriched central nervous system cell populations
12/21/2000DE19928146A1 New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence
12/21/2000DE19927574A1 Increasing content of flavonoids and phenols in plants, useful for e.g. preventing cardiovascular disease, by reducing activity of flavanone-3-hydroxylase
12/21/2000DE19927571A1 Increasing the levels of flavonoids and phenolic compounds in plants comprises treating the plants with growth-regulating 4-acyl-3,5-dioxo-1-cyclohexanecarboxylic acid derivatives
12/21/2000CA2689997A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2381322A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2380860A1 Benzazepine derivative, production and use thereof
12/21/2000CA2379048A1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000CA2377397A1 Il-8 receptor antagonists
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377341A1 Il-8 receptor antagonists
12/21/2000CA2377320A1 Methods for modulating fxr receptor activity
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376933A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000CA2376715A1 Aminotetralin derivative for the therapy of cardiovascular diseases
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2376420A1 Statine-derived tetrapeptide inhibitors of beta-secretase
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376296A1 Urea substituted imidazoquinolines
12/21/2000CA2376288A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000CA2375920A1 Compounds
12/21/2000CA2375851A1 1-azatricyclic-4-benzylpiperazines
12/21/2000CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000CA2375619A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2374555A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/21/2000CA2374239A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373920A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373394A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000CA2370316A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/20/2000EP1061085A2 Synthetic catalytic oligonucleotides
12/20/2000EP1061073A1 (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof
12/20/2000EP1060750A2 Method for treating amyloidosis
12/20/2000EP1060254A2 Human proteinase molecules
1 ... 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 ... 1564